2438 Results for "

decrease

" in MedChemExpress (MCE) Product Catalog:
Products (2438)

2438 Results for "decrease" in MCE Product Catalog:

Art. -Nr.: HY-12938
CAS. Nr.: 1215868-94-2
Target:  

Beta-secretase

Forschungsgebiete:  

Neurological Disease

AMG-8718 is a potent, selective and orally active BACE1 inhibitor with IC50 values of 0.0007, 0.005 µM for BACE1 and BACE2, respectively. AMG-8718 significantly decreases Aβ40 levels in the CSF and brain .
loading...
    loading...
Art. -Nr.: HY-135243
CAS. Nr.: 7264-21-3
Target:  

DNA/RNA Synthesis

Forschungsgebiete:  

Cancer

Ypenyl is a cytostatic. Ypenyl hydrochloride, belonging to the alkylating agent class, exhibits clear genotoxicity and cell cycle disruption properties. Ypenyl induces chromosomal aberrations in broad bean root tip meristem cells and leads to a decrease in the mitotic index. Ypenyl may be used in cancer research .
loading...
    loading...
Art. -Nr.: HY-135761S
CAS. Nr.: 1628110-84-8
Reinheit:  99.17%
Penconazole-d7 is the deuterium labeled Penconazole . Penconazole is a typical triazole fungicide, and mainly applied on apples, grapes, and vegetables to control powdery mildew. Penconazole inhibits sterol biosynthesis in fungi. Penconazole decrease AChE activity in the cerebrum and cerebellum of rats .
loading...
    loading...
Art. -Nr.: HY-138979
CAS. Nr.: 2247911-68-6
Target:  

Lipoxygenase

Forschungsgebiete:  

Others

Lipoxygenin is a non-redox 5-lipoxygenase (5-LO) inhibitor with an IC50 of 5 μM. Lipoxygenin modulates the β-catenin-5-LO complex, inducing a decrease in β-catenin and 5-LO levels in the nucleus .
loading...
    loading...
Art. -Nr.: HY-139850
CAS. Nr.: 2655502-29-5
Target:  

HIV

Forschungsgebiete:  

Infection

GPS491 (EC50 = 0.47 μM) suppresses expression of the HIV-1 structural protein Gag and alters HIV-1 RNA accumulation, decreasing the abundance of RNAs encoding the structural proteins while increasing levels of viral RNAs encoding the regulatory proteins.
loading...
    loading...
Art. -Nr.: HY-147383
CAS. Nr.: 186033-14-7
Target:  

Potassium Channel

Forschungsgebiete:  

Endocrinology

NS-8, a pyrrole derivative, activates the Ca 2+-sensitive k +-channel. NS-8 can suppress the micturition reflex by decreasing afferent pelvic nerve activity. NS-8 can be used in the research of urinary frequency and incontinence .
loading...
    loading...
Art. -Nr.: HY-151987
CAS. Nr.: 3033547-06-4
Target:  

RET Apoptosis

Forschungsgebiete:  

Cancer

RET-IN-20 is a potent RET inhibitor with an IC50 value of 13.7 nM. RET-IN-20 decreases the expression of p-Ret, p-Shc protein. RET-IN-20 induces apoptosis. RET-IN-20 shows antiproliferative and anti-tumor activity .
loading...
    loading...
Art. -Nr.: HY-158829
Target:  

EGFR

Forschungsgebiete:  

Cancer

SSOe26 sodium is a 15mer antisense oligonucleotide targeting?HER4. SSOe26 sodium induces exon 26 skipping, leading to the generation of a novel mRNA transcript that excludes exon 26 (CYT2 isoform). SSOe26 sodium decreases tumour growth in mouse xenografts.
loading...
    loading...
Art. -Nr.: HY-161454
Forschungsgebiete:  

Infection

Antiviral agent 54 (compound 33) is a broad-spectrum and orally active antiviral agent. Antiviral agent 54 shows antiviral activity for ZIKV, HCoV-OC43 and influenza A virus (IVA). Antiviral agent 54 decreases the ZIKV RNA and protein level .
loading...
    loading...
Art. -Nr.: HY-179624
Forschungsgebiete:  

Neurological Disease

cGAS-IN-7 is a cyclic GMP-AMP synthase (cGAS) inhibitor with an IC50 of 0.66 μM for human cGAS. cGAS-IN-7 modestly decreases cGAMP levels in THP1 cells. cGAS-IN-7 can be used for the research of Alzheimer's disease .
loading...
    loading...
Art. -Nr.: HY-179656
CAS. Nr.: 2455422-89-4
UA2239 is an antimalarial agent and acyclic nucleoside phosphonate. UA2239 disrupts the essential cGMP-dependent egress pathway by decreasing cGMP levels. UA2239 targets guanylyl cyclase α. UA2239 demonstrates rapid and irreversible inhibitory effects on Plasmodium parasites .
loading...
    loading...
Art. -Nr.: HY-180422
CAS. Nr.: 95999-11-4
Target:  

Dopamine Receptor

Forschungsgebiete:  

Neurological Disease

(-)-UH 232 is a central dopamine (DA) receptor agonist. (-)-UH 232 weakly decreases 3, 4-dihydroxyphenylalanine (DOPA) formation in striatal and limbic brain regions in rats. (-)-UH 232 can be used for the research of neurological diseases including parkinson's disease and schizophrenia .
loading...
    loading...
Art. -Nr.: HY-B0452R
CAS. Nr.: 23239-51-2
Synonyms: DU21220 hydrochloride (Standard)
Forschungsgebiete:  

Endocrinology

Ritodrine (hydrochloride) (Standard) is the analytical standard of Ritodrine (hydrochloride). This product is intended for research and analytical applications. Ritodrine (DU21220) hydrochloride is a potent and orally active β-adrenergic agonist. Ritodrine hydrochloride decreases preterm delivery and uterine contraction. Ritodrine hydrochloride has the potential for the research of preterm labor .
loading...
    loading...
Art. -Nr.: HY-B0588A
CAS. Nr.: 150937-43-2
Synonyms: AL-4862 hydrochloride
Target:  

Carbonic Anhydrase

Forschungsgebiete:  

Neurological Disease

Brinzolamide (AL-4862) hydrochloride is a selective carbonic anhydrase II inhibitor with an IC50 value of 3.2 nM. Brinzolamide hydrochloride reduces intraocular pressure (IOP) by inhibiting ciliary CA-II and decreasing atrial fluid secretion. Brinzolamide hydrochloride can be used in glaucoma disease research .
loading...
    loading...
Art. -Nr.: HY-D0186S8
CAS. Nr.: 40632-23-3
2'-Deoxyuridine-d2-1 is the deuterium labeled 2'-Deoxyuridine . 2'-Deoxyuridine could increase chromosome breakage and results in a decreased thymidylate synthetase activity. A known use of 2'-Deoxyuridine is as a precursor in the synthesis of Edoxudine .
loading...
    loading...
Art. -Nr.: HY-N0471B
CAS. Nr.: 306-03-6
Synonyms: Hyoscyamine hydrobromide
Target:  

mAChR

Forschungsgebiete:  

Neurological Disease

L-Hyoscyamine (Hyoscyamine) hydrobromide is an anticholinergic agent that may potentially affect breastfeeding and milk production. L-Hyoscyamine hydrobromide is not likely to interfere with breastfeeding when used in single doses. L-Hyoscyamine hydrobromide should be monitored for signs of decreased lactation during long-term use.
loading...
    loading...
Art. -Nr.: HY-P10359
Target:  

TGF-beta/Smad MMP

Forschungsgebiete:  

Neurological Disease

TAT-QFNP12 is a peptide that blocks the NDRG2-PPM1A binding and reduces Smad2/3 phosphorylation, decreases astrocytic MMP-9 production and BBB disruption after subarachnoid hemorrhage (SAH) .
loading...
    loading...
Art. -Nr.: HY-P10359A
Target:  

TGF-beta/Smad MMP

Forschungsgebiete:  

Neurological Disease

TAT-QFNP12 acetate is a peptide that blocks the NDRG2-PPM1A binding and reduces Smad2/3 phosphorylation, decreases astrocytic MMP-9 production and BBB disruption after subarachnoid hemorrhage (SAH) .
loading...
    loading...
Art. -Nr.: HY-P11222
CAS. Nr.: 2614435-43-5
Forschungsgebiete:  

Neurological Disease

Tat-SERT-15C is a peptide. Tat-SERT-15C decreases the SERT-nNOS complex and increases SERT. Tat-SERT-15C reverses chronic unpredictable mild stress-caused depression behaviors .
loading...
    loading...
Art. -Nr.: HY-P1385
Target:  

GSK-3 p38 MAPK

Forschungsgebiete:  

Neurological Disease

TCS 183, a peptide, is a GSK-3β inhibitor. TCS 183 blocks GSK-3β autoinhibition and decreases the level of AMPK phosphorylation. TCS 183 can be used for neuropathological diseases, particularly Alzheimer’s disease, research .
loading...
    loading...